BIT
MACK

BlackRock Institutional Trust’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

BlackRock Institutional Trust’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.1M Sell
407,541
-34,298
-8% -$1.46M ﹤0.01% 2241
2016
Q3 		$22.1M Buy
441,839
+57,001
+15% +$2.37M ﹤0.01% 1824
2016
Q2 		$16.3M Buy
384,838
+23,615
+7% +$1.29M ﹤0.01% 1979
2016
Q1 		$23.8M Sell
361,223
-7,888
-2% -$412K ﹤0.01% 1699
2015
Q4 		$22.9M Buy
369,111
+40,943
+12% +$2.88M ﹤0.01% 1764
2015
Q3 		$22M Buy
328,168
+33,022
+11% +$2.7M ﹤0.01% 1777
2015
Q2 		$28.7M Sell
295,146
-12,431
-4% -$1.18M ﹤0.01% 1670
2015
Q1 		$28.7M Buy
307,577
+73,796
+32% +$6.28M ﹤0.01% 1704
2014
Q4 		$20.8M Buy
233,781
+90,593
+63% +$6.6M ﹤0.01% 1875
2014
Q3 		$9.89M Sell
143,188
-10,525
-7% -$562K ﹤0.01% 2353
2014
Q2 		$8.82M Sell
153,713
-1,242
-0.8% -$63.1K ﹤0.01% 2509
2014
Q1 		$6.14M Buy
154,955
+3,460
+2% +$148K ﹤0.01% 2701
2013
Q4 		$6.35M Sell
151,495
-5,355
-3% -$155K ﹤0.01% 2675
2013
Q3 		$4.68M Sell
156,850
-15,549
-9% -$544K ﹤0.01% 2768
2013
Q2 		$9.14M Buy
+172,399
New +$7.56M ﹤0.01% 2370

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

BlackRock Institutional Trust's MACK Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Merrimack Pharmaceuticals, Inc. (MACK) stake by 7.8% in Q4 2016, selling an estimated $1.46M and leaving 407,541 shares worth $13.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

BlackRock Institutional Trust first reported a position in MACK in Q2 2013 and has held it in 15 quarters since. The position peaked at $28.7M in Q1 2015. 136 funds tracked by Wall St. Rank hold MACK as of Q4 2016.

  • BlackRock Institutional Trust held 407,541 shares of Merrimack Pharmaceuticals, Inc. worth $13.1M as of Q4 2016.
  • BlackRock Institutional Trust sold 34,298 Merrimack Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.46M.
  • Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2241 holding.
  • BlackRock Institutional Trust first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Merrimack Pharmaceuticals, Inc. position peaked at $28.7M in Q1 2015.
  • 136 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.